Skip to main content

Characterization, comparison, and cross-validation of in vivo alpha-synuclein models of parkinsonism.

Terina. N. Martinez1, Michael Sasner2, Mark T. Herberth3, Robert C. Switzer III4, S.O. Ahmad5, Kelvin C. Luk6, Sylvie Ramboz7, Andrea E. Kudwa7, Deniz Kirik8, Joe Flores8, Ronald J. Mandel9, Matthew P. Getz9, Ryan Brown9, Joshua C. Grieger10, R. Jude Samulski10, David Dismuke10, Sonal S. Das11, Mark A. Frasier1, and Kuldip D. Dave1

1The Michael J. Fox Foundation for Parkinson’ s Research, 2The Jackson Laboratory, 3WIL Research, 4NeuroScience Associates, 5Saint Louis University, 6Universityof Pennsylvania Perelman School of Medicine, 7PsychoGenics, Inc., 8BRAINS Unit, Lund University, 9McKnight Brain Inst., University of Florida,10Gene Therapy Center, University of North Carolina at Chapel Hill, 11MRC Protein Phosphorylation & Ubiquitylation Unit, University of Dundee

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.